We are live on ! Find out more
MIRM icon

Mirum Pharmaceuticals
MIRM

104 hedge funds and large institutions have $650M invested in Mirum Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 47 increasing their positions, 25 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

206% more call options, than puts

Call options by funds: $422K | Put options by funds: $138K

88% more repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 25

50% more funds holding in top 10

Funds holding in top 10: 4 → 6 (+2)

3% less capital invested

Capital invested by funds: $673M → $650M (-$23.1M)

2.76% less ownership

Funds ownership: 93.18% → 90.42% (-2.8%)

7% less funds holding

Funds holding: 112 → 104 (-8)

30% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 23

Holders
104
Holders Change
-8
Holders Change %
-7.14%
% of All Funds
1.67%
Holding in Top 10
6
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+50%
% of All Funds
0.1%
New
16
Increased
47
Reduced
25
Closed
23
Calls
$422K
Puts
$138K
Net Calls
+$284K
Net Calls Change
-$80K

Top Buyers

1
EAM
Eventide Asset Management
Massachusetts
+$15.5M
2
State Street
State Street
Massachusetts
+$15.2M
3
TCM
Tang Capital Management
California
+$13.2M
4
Citadel Advisors
Citadel Advisors
Florida
+$9.55M
5
BlackRock
BlackRock
New York
+$7.66M

Top Sellers

1
Franklin Resources
Franklin Resources
California
-$22.4M
2
CCM
Cadian Capital Management
New York
-$19.5M
3
Victory Capital Management
Victory Capital Management
Texas
-$14.6M
4
FLAM
First Light Asset Management
Minnesota
-$11M
5
PCH
Polar Capital Holdings
United Kingdom
-$6.42M
Name Holding Trade Value Shares
Change 		Change in
Stake
SAM
51
Secure Asset Management
Michigan
$842K +$853K +43,172 New
Invesco
52
Invesco
Georgia
$798K +$167K +8,465 +26%
AAA
53
Affinity Asset Advisors
New York
$780K +$791K +40,000 New
JCIA
54
Jackson Creek Investment Advisors
Colorado
$654K -$74.3K -3,760 -10%
ClearBridge Investments
55
ClearBridge Investments
New York
$608K +$207K +10,470 +51%
Russell Investments Group
56
Russell Investments Group
United Kingdom
$582K -$3.41M -172,394 -85%
JF
57
Jump Financial
Illinois
$488K -$92.5K -4,681 -16%
Voloridge Investment Management
58
Voloridge Investment Management
Florida
$487K +$494K +24,989 New
California State Teachers Retirement System (CalSTRS)
59
California State Teachers Retirement System (CalSTRS)
California
$481K +$7.31K +370 +2%
AllianceBernstein
60
AllianceBernstein
Tennessee
$470K +$69.2K +3,500 +17%
RhumbLine Advisers
61
RhumbLine Advisers
Massachusetts
$445K +$14.3K +724 +3%
PAM
62
Panagora Asset Management
Massachusetts
$415K -$1.06M -53,762 -72%
Susquehanna International Group
63
Susquehanna International Group
Pennsylvania
$407K -$118K -5,994 -22%
UBS AM
64
UBS AM
Illinois
$393K +$399K +20,164 New
RJA
65
Raymond James & Associates
Florida
$385K -$1.01M -51,256 -72%
State of Wisconsin Investment Board
66
State of Wisconsin Investment Board
Wisconsin
$374K -$23.1K -1,168 -6%
Janney Montgomery Scott
67
Janney Montgomery Scott
Pennsylvania
$357K -$21.7K -1,100 -6%
T. Rowe Price Associates
68
T. Rowe Price Associates
Maryland
$328K +$94.9K +4,800 +40%
VEA
69
Virtus ETF Advisers
New York
$327K +$88.4K +4,472 +36%
Squarepoint
70
Squarepoint
New York
$295K +$299K +15,117 New
AQR Capital Management
71
AQR Capital Management
Connecticut
$279K +$70.7K +3,579 +33%
CS
72
Credit Suisse
Switzerland
$235K -$2.85K -144 -1%
New York State Common Retirement Fund
73
New York State Common Retirement Fund
New York
$218K -$158 -8 -0.1%
Mirae Asset Global Investments
74
Mirae Asset Global Investments
South Korea
$198K +$201K +10,145 New
Federated Hermes
75
Federated Hermes
Pennsylvania
$195K +$197K +9,985 +66,567%
1 2
3
4 5

MIRM Hedge Fund Activity: Q4 2022 in Review

104 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Mirum Pharmaceuticals (MIRM) for Q4 2022, worth a combined $650M — down 3.4% from $673M a quarter earlier.

Sellers outnumbered buyers: 23 funds closed out of MIRM and 16 opened new positions — a net loss of 7 holders — while 25 trimmed existing stakes and 47 added.

The largest buyer was Eventide Asset Management, adding an estimated $15.5M. The largest seller was Franklin Resources, cutting an estimated $22.4M.

  • 104 institutional investors held Mirum Pharmaceuticals (MIRM) as of Q4 2022, down from 112 in Q3 2022.
  • Funds reported $650M of Mirum Pharmaceuticals stock for Q4 2022, down 3.4% quarter-over-quarter.
  • 16 funds opened new Mirum Pharmaceuticals positions in Q4 2022 and 23 closed out, a net change of -7 holders.
  • The largest Mirum Pharmaceuticals buyer in Q4 2022 was Eventide Asset Management, an estimated $15.5M added.
  • The largest Mirum Pharmaceuticals seller in Q4 2022 was Franklin Resources, an estimated $22.4M sold.

Based on aggregated 13F filings for Q4 2022.